467 related articles for article (PubMed ID: 17079736)
1. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.
Horiuchi K; Le Gall S; Schulte M; Yamaguchi T; Reiss K; Murphy G; Toyama Y; Hartmann D; Saftig P; Blobel CP
Mol Biol Cell; 2007 Jan; 18(1):176-88. PubMed ID: 17079736
[TBL] [Abstract][Full Text] [Related]
2. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.
Sahin U; Weskamp G; Kelly K; Zhou HM; Higashiyama S; Peschon J; Hartmann D; Saftig P; Blobel CP
J Cell Biol; 2004 Mar; 164(5):769-79. PubMed ID: 14993236
[TBL] [Abstract][Full Text] [Related]
3. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.
Hinkle CL; Sunnarborg SW; Loiselle D; Parker CE; Stevenson M; Russell WE; Lee DC
J Biol Chem; 2004 Jun; 279(23):24179-88. PubMed ID: 15066986
[TBL] [Abstract][Full Text] [Related]
4. Regulated ADAM17-dependent EGF family ligand release by substrate-selecting signaling pathways.
Dang M; Armbruster N; Miller MA; Cermeno E; Hartmann M; Bell GW; Root DE; Lauffenburger DA; Lodish HF; Herrlich A
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9776-81. PubMed ID: 23720309
[TBL] [Abstract][Full Text] [Related]
5. ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha.
Le Gall SM; Bobé P; Reiss K; Horiuchi K; Niu XD; Lundell D; Gibb DR; Conrad D; Saftig P; Blobel CP
Mol Biol Cell; 2009 Mar; 20(6):1785-94. PubMed ID: 19158376
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H
Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575
[TBL] [Abstract][Full Text] [Related]
7. The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands.
Urriola-Muñoz P; Li X; Maretzky T; McIlwain DR; Mak TW; Reyes JG; Blobel CP; Moreno RD
J Cell Physiol; 2018 Mar; 233(3):2247-2256. PubMed ID: 28703301
[TBL] [Abstract][Full Text] [Related]
8. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk.
Higashiyama S; Nanba D
Biochim Biophys Acta; 2005 Aug; 1751(1):110-7. PubMed ID: 16054021
[TBL] [Abstract][Full Text] [Related]
9. TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase.
Lee DC; Sunnarborg SW; Hinkle CL; Myers TJ; Stevenson MY; Russell WE; Castner BJ; Gerhart MJ; Paxton RJ; Black RA; Chang A; Jackson LF
Ann N Y Acad Sci; 2003 May; 995():22-38. PubMed ID: 12814936
[TBL] [Abstract][Full Text] [Related]
10. ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding.
Yin J; Yu FS
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):132-9. PubMed ID: 18658095
[TBL] [Abstract][Full Text] [Related]
11. Cell surface annexins regulate ADAM-mediated ectodomain shedding of proamphiregulin.
Nakayama H; Fukuda S; Inoue H; Nishida-Fukuda H; Shirakata Y; Hashimoto K; Higashiyama S
Mol Biol Cell; 2012 May; 23(10):1964-75. PubMed ID: 22438584
[TBL] [Abstract][Full Text] [Related]
12. A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1).
Breshears LM; Schlievert PM; Peterson ML
J Biol Chem; 2012 Sep; 287(39):32578-87. PubMed ID: 22833676
[TBL] [Abstract][Full Text] [Related]
13. VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling.
Swendeman S; Mendelson K; Weskamp G; Horiuchi K; Deutsch U; Scherle P; Hooper A; Rafii S; Blobel CP
Circ Res; 2008 Oct; 103(9):916-8. PubMed ID: 18818406
[TBL] [Abstract][Full Text] [Related]
14. PKCα and PKCδ regulate ADAM17-mediated ectodomain shedding of heparin binding-EGF through separate pathways.
Kveiborg M; Instrell R; Rowlands C; Howell M; Parker PJ
PLoS One; 2011 Feb; 6(2):e17168. PubMed ID: 21386996
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of EGFR ligands on endocytic sorting of the receptor.
Roepstorff K; Grandal MV; Henriksen L; Knudsen SL; Lerdrup M; Grøvdal L; Willumsen BM; van Deurs B
Traffic; 2009 Aug; 10(8):1115-27. PubMed ID: 19531065
[TBL] [Abstract][Full Text] [Related]
16. A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17.
Maretzky T; Zhou W; Huang XY; Blobel CP
Oncogene; 2011 Feb; 30(5):611-8. PubMed ID: 20871631
[TBL] [Abstract][Full Text] [Related]
17. Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis.
Oshima H; Popivanova BK; Oguma K; Kong D; Ishikawa TO; Oshima M
Cancer Sci; 2011 Apr; 102(4):713-9. PubMed ID: 21205091
[TBL] [Abstract][Full Text] [Related]
18. The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events.
Moss ML; Bomar M; Liu Q; Sage H; Dempsey P; Lenhart PM; Gillispie PA; Stoeck A; Wildeboer D; Bartsch JW; Palmisano R; Zhou P
J Biol Chem; 2007 Dec; 282(49):35712-21. PubMed ID: 17895248
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of sigma-1 receptor inhibits ADAM10 and ADAM17 mediated shedding in vitro.
Li J; Liu B; Gao X; Ma Z; CaoSong T; Mei YA; Zheng Y
Protein Cell; 2012 Feb; 3(2):153-9. PubMed ID: 22322890
[TBL] [Abstract][Full Text] [Related]
20. EGF promotes the shedding of soluble E-cadherin in an ADAM10-dependent manner in prostate epithelial cells.
Grabowska MM; Sandhu B; Day ML
Cell Signal; 2012 Feb; 24(2):532-538. PubMed ID: 22024284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
